Adult neurogenesis in human brain is known to occur in the hippocampus, the subventricular zone, and the striatum. Neural progenitor cells (NPCs) were reported in the cortex of epilepsy patients; however, their identity is not known. Since astrocytes were proposed as the source of neural progenitors in both healthy and diseased brain, we tested the hypothesis that NPCs in the epileptic cortex originate from reactive, alternatively, de-differentiated astrocytes that express glutamate aspartate transporter (GLAST). We assessed the capacity to form neurospheres and the differentiation potential of cells dissociated from fresh cortical tissue from patients who underwent surgical treatment for pharmacologically intractable epilepsy. Neurospheres were generated from 57% of cases (8/14). Upon differentiation, the neurosphere cells gave rise to neurons, oligodendrocytes, and astrocytes. Sorting of dissociated cells showed that only cells negative for GLAST formed neurospheres. In conclusion, we show that cells with neural stem cell properties are present in brain cortex of epilepsy patients, and that these cells are not GLAST-positive astrocytes.
Introduction
The first hypotheses of adult neurogenesis were formulated in the 1960s and it became well established that neurogenesis occurs in the adult human brain throughout life (Eriksson et al. 1998; Ernst et al. 2014; Ernst and Frisen 2015) . In the adult human brain, neural progenitor cells (NPCs) are present in the subventricular zone (Curtis et al. 2007 ), the hippocampus (Eriksson et al. 1998; Spalding et al. 2013) , and the striatum (Ernst et al. 2014) . In rodents, reactive, de-differentiated astrocytes as found in reactive gliosis in some neurological conditions such as for example after traumatic brain injury or stroke, have been shown to exhibit properties of NPCs (Buffo et al. 2008; Magnusson et al. 2014) . However, the origin of multipotent NPCs obtained from human brain cortical surgical resections (Kirschenbaum et al. 1994; Arsenijevic et al. 2001; Nunes et al. 2003) is still under debate. Since reactive gliosis (Pekny and Pekna 2014; Pekny et al. 2016) was also reported to be triggered in the tissue within and adjacent to epileptic foci (Hinterkeuser et al. 2000; de Lanerolle and Lee 2005) , we tested the hypothesis that reactive astrocytes in the adult and juvenile human cerebral cortex from epileptic patients are the source of cells with NPC properties.
Glutamate aspartate transporter (GLAST), known also as EAAT1 or SLC1A3, an integral membrane glycoprotein, regulates the excitatory neurotransmitter L-glutamate by removing L-glutamate from the extracellular space (Jungblut et al. 2012) . Given that GLAST is exclusively expressed on the cell membrane of most of the astroglial subpopulations including reactive astrocytes (Mori et al. 2006b; Buffo et al. 2008; Jungblut et al. 2012) , it constitutes a suitable cell membrane marker for antibody-based isolation of astrocytes, including reactive astrocytes. We therefore used anti-GLAST antibody conjugated magnetic microbeads to isolate the GLAST pos astrocyte fraction from human cortical tissue obtained from surgeries performed for pharmacologically intractable epilepsy, and investigated the neurosphere-forming capacity of the GLAST pos and GLAST neg cell populations.
Materials and Methods

Human Specimen Preparation
Human cerebral cortex tissue was obtained from 19 patients operated for pharmacologically intractable epilepsy (2.5-45 years old, 10 females, 9 males). Brain surgery took place at Sahlgrenska University Hospital, Gothenburg, Sweden. During the surgery, the resected tissue was divided into a research specimen and a specimen that was used for histopathological diagnosis.
Research specimens were collected and immediately transferred into cold Hybernate A medium (Invitrogen) for transportation to the cell culture facility. Preoperative MRI in combination with the 3D neuronavigation system and intraoperative photographs allowed to document and define the location of research specimens ( Fig. 1A ) and to rule out the possibility that these included the subventricular zone or the hippocampus. Research specimens were collected in accordance with the ethical guidelines of the Sahlgrenska University Hospital and approval was obtained from the Regional ethical review board in Gothenburg (Dnr 179-08). Specimens for histopathological assessment were processed, and evaluated in the Department of Pathology at Sahlgrenska University Hospital, Sweden. Briefly, the sections from paraffin embedded tissue blocks were either histochemically labeled with hematoxylin-eosin and Luxol fast blue, or immunolabeled using a Dako Autostainer Link (Dako), with a mouse monoclonal antibody against GFAP (1:10 000; Leica Microsystems) or a mouse monoclonal antibody against synaptophysin (a ready to use preparation; Leica Microsystems). Reactive gliosis was graded in an arbitrary 3 tier scale with the help of GFAP immunolabeling. Cortical dysplasia and hippocampal sclerosis were graded according to the International League Against Epilepsy (ILAE) classification systems (Blumcke et al. 2011 (Blumcke et al. , 2013 .
Single-Cell Dissociation and GLAST Separation
The gray matter tissue with a possible minor contamination by subcortical white matter, was dissociated using MACS brain tumor dissociation T kit (Miltenyi Biotech) according to manufacturer's protocol. For specimen No. 9 and 12, separate preparations from gray matter and subcortical white matter tissue were included. The resulting single-cell suspension was purified with MACS myelin removal microbeads (Miltenyi Biotech) to remove the myelin debris (not applied to specimens No. I-V). The isolated cells were sorted using MACS anti-GLAST (ASCA-1) microbeads (not applied to specimens No. 1-3; Miltenyi Biotech). For protein extraction and western blot analysis, cryopreserved purified dissociated brain cells from specimen No. 5 were used.
Protein Extraction
Protein extraction protocols were previously described (Puschmann et al. 2013) . In brief, total protein from GLAST sorted GLAST pos and GLAST neg cells was harvested by adding 50 µL protein lysis buffer to collected cells. The protein lysis buffer was composed of 20 mM Tris-HCL (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% v/v Triton-X 100, one tablet of protease inhibitor (Roche)/10 mL lysis buffer, and one tablet of phosphatase inhibitor (Roche)/10 mL lysis buffer. The protein lysates were sonicated for 15 s at 14 amplitude microns followed by protein concentration measurement by using Bio-Rad DC protein assay (Bio-Rad).
Western Blot Analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed using Any-kD polyacrylamide gels (Bio-Rad) and Tris-glycine running buffer (Bio-Rad). A total amount of 12 μg of protein lysate per lane was loaded. Separated proteins were blotted on PVDF membranes (0.2 µm; Millipore/Immobilon) for 2 h at 100 V, 300 mA. Transfer buffer was composed of Tris-base (2.9 g/L), glycine (14.4 g/L), and MeOH (10% v/v) in dH 2 O. Unspecific binding was blocked overnight at 4°C using 3% bovine serum albumin in Tris-buffered saline containing 0.1% TWEEN. Incubation with primary antibodies was conducted at 4°C overnight followed by incubation with secondary HRPlinked anti-mouse antibodies (1:2000; Cell Signaling) for 45 min at room temperature (RT). Secondary HRP-linked antibodies were detected using ECL western blotting detection reagents (GE Healthcare) and a LAS-3000 luminescent image analyzer (Fujifilm). The following primary antibodies were used: mouse anti-GLAST (1:1000; Miltenyi Biotech), mouse anti-GFAP (1:1500; Millipore), and HRP-linked anti-beta-actin (1:1500; Cell Signaling).
Neurosphere Culture and Passaging GLAST pos and GLAST neg cells were cultured in neurosphere growth medium in 12-well cell suspension plates (Greiner BioOne) at densities of 2500, 5000, and 7500 cells/mL. Neurosphere growth medium was composed of Neurobasal medium (Life/ Gibco), supplemented with 1% Pen/Strep (Life/Gibco), 1% L-Glutamine (Life/Gibco), 2% B27 without Vitamin A (Life/Gibco), 20 ng/mL bFGF (Life/Gibco), 20 ng/mL EGF (Life/Gibco) and 1 U/mL Heparin (Sigma-Aldrich). The neurospheres were counted and passaged at 10 or 14 days in vitro (DIV). Non-spherical cell clusters smaller than 50 µm in diameter were not considered neurospheres and excluded from neurosphere counts. To passage primary neurospheres, the neurospheres were manually collected under an inverted bright-field microscope and incubated in 0.25% Trypsin-EDTA (Life/Gibco) at 37°C for 10 min or in Accutase (Life/Gibco) at RT for 10 min or in TrypLE Select 1X (Life/Gibco) at 37°C for 10 min, mechanically dissociated and re-suspended in fresh growth medium at densities of 2500 and 5000 cells/mL. To verify that anti-GLAST microbeads bound to the cell surface did not have a negative effect on neurosphere formation, we assessed neurosphere formation of mouse neurosphere cells sorted by oligodendrocyte precursor cell-specific MACS anti-A2B5 microbeads (Miltenyi Biotech). In brief, whole brain (without cerebellum) of an adult C57BL/6 mouse was dissociated using the same methods as described above, and the cells were allowed to form neurospheres. Neurospheres were incubated in Accutase (Life/Gibco) at RT for 10 min, mechanically dissociated into single cells, and subsequently sorted by anti-A2B5 microbeads (Miltenyi Biotech) according to the manufacturer's protocol.
Cell Proliferation Assays
The exogenous uptake of 5-ethynyl-2′-deoxyuridine (EdU) into the nuclei was detected using the Click-iT kit (Life/Invitrogen) according to the manufacturer's protocol. In brief, neurospheres were incubated with 10 μM EdU for 6 h, fixed in 4% paraformaldehyde (PFA) for 20 min, and blocked in blocking buffer (DPBS with 2% donkey serum, 2% goat serum, and 0.1% Triton-X 100). Incorporated EdU was visualized with Alexa Fluor 594 azide (Click-iT kit, Life/Invitrogen) and cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI; 1:2000; SigmaAldrich). 5-bromo-2′-deoxyuridine (BrdU) labeling was applied to neurosphere cultures generated from specimen No. 14 to assess cell proliferation and differentiation. The neurospheres were incubated with 0.5 μM BrdU (Sigma-Aldrich) for 48 h, then were either fixed in 4% PFA for BrdU detection, or dissociated and allowed to differentiate on poly-L-ornithine (10 µg/mL in dH 2 O at 37°C for 2 h; Sigma-Aldrich) and laminin (5 µg/mL in DPBS at 37°C overnight; Life/Invitrogen) coated 24-well plates (Fisher Scientific/TPP) as described below. For quantification of BrdU labeled neurosphere cells, dissociated primary neurospheres were cultured in poly-L-ornithine and laminin coated 24-well plates (Fisher Scientific/TPP) with neurosphere growth medium for 5 days, followed by incubation with 0.5 μM BrdU for 48 h, and then fixed in 4% PFA. For detection of BrdU, PFA fixed cells were treated with 1 M HCl at RT for 8 min and then with 2 M HCl at 37°C for 15 min. BrdU incorporation was visualized by immunolabeling as described below.
Neurosphere Differentiation
At 10 or 14 DIV primary neurospheres were manually collected using an inverted bright-field microscope. The undissociated neurospheres or dissociated neurosphere cells with or without BrdU labeling were allowed to differentiate in differentiation medium on poly-L-ornithine and laminin coated coverslips (Fisher Scientific/TPP) and 24-well plates (Fisher Scientific/TPP). Differentiation medium was composed of Neurobasal medium (Life/Gibco) supplemented with 1% Pen/Strep (Life/Gibco), 1% L-Glutamine (Life/Gibco), 2% B27 (Life/Gibco), and 0.1% heat-inactivated fetal calf serum (HyClone/ ThermoFisher). Differentiated cells were cultured for 1-2 weeks before examination.
Immunohistochemistry
Cells were washed in DPBS and fixed in 4% PFA, followed by blocking unspecific binding sites using blocking buffer (DPBS supplemented with 2% donkey serum, 2% goat serum, and 0.1% Triton-X 100). Proteins of interest were detected using the fol- 
Results
Cells Isolated from Human Epileptic Cortex Give Rise to Neurospheres In Vitro
To determine the presence of NPCs among cells isolated from human epileptic cortical tissue, we used the neurosphereforming assay (Table 1 ). The position of the research specimen was determined by 3D neuronavigation system in combination of preoperative MRI and intraoperative photographs (Fig. 1A) . As expected, histopathological examination showed varying degree of reactive gliosis in the resected tissue, which might be related to differences between patients in epilepsy duration, seizure frequency, or severity (Table 1) . Cells derived from specimens No. I-V formed mainly nonspherical cell clusters, which did not expand in size, did not adhere or differentiate under differentiation-inducing culture conditions. It was previously reported that neurosphere formation can be triggered by clustering of proliferating cells (Mori et al. 2006a) . We reasoned that the observed lack of neurosphere formation was likely due to the abundant cell debris, a byproduct of the tissue dissociation, surrounding the living cells and inhibiting free cell-cell contacts. To remove the myelin debris and to allow cell-cell contacts to occur in the subsequent specimens, we used myelin removal beads. We observed neurosphere formation from 8 out of 14 (57%) of the dissociated resected specimens subjected to the myelin removal procedure. We did not observe any association between neurosphere formation and the presence of invasive electrode monitoring or patient's gender.
GLAST
neg but Not GLAST pos Cell Population Contains
Neurosphere-Forming Cells
GLAST is expressed in astrocytes, including reactive astrocytes (Mori et al. 2006b; Buffo et al. 2008; Jungblut et al. 2012 ) and hence is a suitable cell surface marker protein to identify and isolate astrocytes. To test the hypothesis that reactive astrocytes in the human cortex are the source of NPCs, we next assessed the in vitro neurosphere-forming capacity of GLAST pos and GLAST neg cell populations isolated from dissociated cortical tissue by using anti-GLAST antibody conjugated magnetic microbeads. The anti-GLAST antibody (Miltenyi Biotech) was demonstrated to label virtually all astrocytes positive for GFAP (Jungblut et al. 2012; Shimada et al. 2012 ). The GLAST pos cells constituted a large proportion (63-91%) of the dissociated cells from human cortical tissue (Table 2) . First, we validated the quality of GLAST pos cell isolation and assessed potential adverse effects of the cell surface bound magnetic microbeads on the ability of cells to form neurospheres. Western blot analysis indicated a distinct separation of GLAST pos and GLAST neg cells as determined by GLAST protein expression (Fig. 1B) . The expression of reactive astrocyte marker protein GFAP was substantially higher in GLAST pos cell population, confirming that the GLAST pos isolated cell population is astrocyte-enriched (Fig. 1B) . We assessed the potential adverse effects of cell surface bound magnetic microbeads on neurosphere formation by sorting dissociated mouse neurosphere cells using anti-A2B5 microbeads and determining the ability of these passaged cells to form secondary neurospheres. A2B5 is a cell surface protein expressed by oligodendrocyte precursor cells, a subpopulation of NPCs known to give rise to neurospheres in vitro (Gard and Pfeiffer 1990; Mokry et al. 2008) . We found that both the A2B5 pos (Fig. 1C' ) and A2B5 neg ( Fig. 1C"' ) cell fractions gave rise to neurospheres (Fig. 1C" and 1C"" ). These results show that cell-bound microbeads do not prevent neurosphere formation. Next, we compared the neurosphere-forming capacity of the GLAST pos and GLAST neg cell populations. Surprisingly, the GLAST pos cell population did not give rise to neurospheres (Table 1) , we detected none or only minute number of cell clusters that disintegrated over time (Fig. 1D') . In contrast, the GLAST neg cell population formed neurospheres that continuously expanded in size (Fig. 1D") . The density of neurospheres varied among specimens, ranging from 11 to 118 per 10 000 seeded cells (Table 3) , the size of neurospheres varied between 50 and 150 µm in diameter ( Fig. 1D" and 1D"' ). To confirm that the GLAST neg cells have the capacity to form neurosphere regardless of whether they are isolated from the gray or white matter, we separated gray and white matter tissue of specimen 12 prior to tissue dissociation and found that neurospheres formed from GLAST neg cells derived from both tissue preparations (Table 3) .
Human Epileptic Cortex-Derived Neurospheres Show Self-Renewal
To assess the NPC properties of the neurospheres, we investigated self-renewal and proliferation rate of the neurosphere cells. The self-renewing capacity of neurospheres was assessed by propagation of secondary neurospheres (neurospheres from specimens No. 11, 12, and 14) . In all 3 cases, secondary neurospheres were successfully generated and their size and appearance were comparable to the respective ancestral primary neurospheres ( Fig. 1D"' ). Tertiary neurospheres were generated from specimen No. 14 ( Table 3 ), indicating that the neurosphere cells are capable of self-renewal. Given the low plating density of the single cells from which each secondary and tertiary neurosphere was derived and the fact that the secondary neurosphere-forming cells originated from primary neurospheres that had formed from single-cell dissociates, the secondary and tertiary neurospheres were with high probability of clonal origin. Next, we assessed cell proliferation within randomly selected neurospheres by using EdU or BrdU proliferation assays. After Fig. 1E and 1F) . Many of the proliferating cells were positive for nestin, a NPC marker expressed also in a subpopulation of astrocytes (Fig. 1F) . The dissociated neurosphere cells proliferated also in adherent monolayer cultures in the presence of EGF and bFGF. In 2 separate experiments, 32.5% ± 4.9% of neurosphere cells were BrdU pos after 48 h long incubation with BrdU. The majority of BrdU pos cells were nestin pos (93%; Fig. 1G ), and many of the BrdU pos cells were NG2 pos (48%; Fig. 1H ). Jointly, these results show that the neurosphere cells are capable of self-renewal.
Human Epileptic Cortex-Derived Neurosphere Cells are Multipotent
Next, we assessed the differentiation potential of the neurosphere cells by using differentiation assays on undissociated primary neurospheres (from specimens No. 9 and 12) and immunolabeling with the antibodies against the astrocyte marker GFAP, the neuronal marker βIII-tubulin and NPC/reactive astrocyte marker nestin (Fig. 2) . Under differentiation permissive conditions, cells from neurospheres formed long cellular processes and migrated out from the core of the original neurosphere (Fig. 2C ). Both neurons (βIII-tubulin pos / GFAP neg ) and astrocytes (GFAP pos /βIII-tubulin neg ) were generated from primary neurospheres (Fig. 2B, 2D , 2E' and 2E"). Large proportion of neurosphere cells was positive for GFAP and βIII-tubulin (Fig. 2B, 2D , 2E', 2E"). The GFAP pos /βIII-tubulin pos cells
showed 2 distinct types of morphology, one with characteristic lamellipodia and filopodia with fine processes, and the other with a bipolar morphology with 2 elongated processes and cell branches ( Fig. 2B and D) . Next, we assessed the multipotency of the neurosphere cells by using differentiation assays on dissociated primary and secondary neurospheres (from specimen No. 14) and immunolabeling with the antibodies against the astrocyte marker GFAP, the neuronal markers βIII-tubulin and MAP2, oligodendrocyte marker O4, and NPC/reactive astrocyte marker nestin (Fig. 3) . were generated from both primary and secondary neurosphere cells (Fig. 3A, 3B, 3C , 3F, 3G, and 3H). The proportions of neurons and astrocytes were comparable between cells of dissociated primary versus secondary neurospheres, as assessed by GFAP/ MAP2 double labeling (Fig. 3F and 3G ). Large proportion of neurosphere cells was positive for both GFAP and MAP2/βIII-tubulin, respectively (Fig. 3A, 3C , 3F, 3G, and 3H). In contrast to the abundance of nestin expressing cells from undissociated neurospheres from specimen No. 9 and 12 cultured on poly-Lornithine/laminin coated coverslips (Fig. 2) , dissociated neurosphere cells from specimen 14 cultured in poly-L-ornithine/ laminin coated culture dishes did not express nestin (Fig. 3E) . When neurospheres were incubated with BrdU for 48 h prior to differentiation, we observed BrdU pos cells in all the 3 cell lineages, that is, neurons, astrocytes, and oligodendrocytes (Fig. 3F, 3G, 3H, and 3I ). These results demonstrate that the neurosphere cells are multipotent.
Discussion
In the adult human brain, NPCs are present in the subventricular zone (Curtis et al. 2007 ), the hippocampus (Eriksson et al. 1998; Spalding et al. 2013) , and the striatum (Ernst et al. 2014) . Rodent astrocytes can generate new neurons after various brain insults (Buffo et al. 2008; Magnusson et al. 2014) . GLAST pos cells were proposed to serve as the source of NPCs in the 2 neurogenic niches, namely subventricular zone (Merkle et al. 2004; Liu et al. 2006) , and the subgranular zone of the dentate gyrus of the hippocampus (Kempermann et al. 2004; Seri et al. 2004) . The new neurons in the adult human striatum are likely to derive from the neighboring subventricular zone (Ernst et al. 2014) ; however, local parenchymal astrocytes have also been suggested as a source of new striatal neurons (Ernst and Frisen 2015) . Although neurogenesis does not occur in adult human cerebral cortex (Bhardwaj et al. 2006; Huttner et al. 2014) , NPCs have been isolated from cortical tissue of patients with epilepsy or other CNS pathologies (Kirschenbaum et al. 1994; Arsenijevic et al. 2001; Nunes et al. 2003) . Here, we provide the evidence that contrary to the injured rodent brain (Buffo et al. 2008) , the NPCs in the epileptic human cortex are not derived from GLAST pos reactive astrocytes. This can be caused by the differences in disease-specific reactive gliosis, or might reflect one of the differences in brain plasticity between mice and man (Ernst and Frisen 2015) . After removal of myelin debris, we successfully generated neurospheres from the tissue of the human cortex. The neurospheres gave rise to secondary and tertiary neurospheres, proliferated and differentiated into neuronal, astrocyte and oligodendrocyte lineages demonstrating their self-renewal and multipotency. GLAST pos cells constituted a large proportion (63-91%) of the dissociated cells, conceivably reflecting the high abundance of astrocytes in the human cerebral cortex (Oberheim et al. 2009 ). The most important finding of our study is that in the adult human cortex, GLAST neg but not the GLAST pos cells are capable of forming neurospheres.
Notably, we have excluded the possibility that the cell surface bound magnetic microbeads inhibit the neurosphere-forming capacity. These results indicate that, unlike reactive astrocytes in the mouse acute brain trauma model (Buffo et al. 2008) , in human cortex, GLAST pos reactive astrocytes do not acquire NPC properties. It is, however, possible that similar to rodent cortex (Buffo et al. 2008; Sirko et al. 2013) , human reactive astrocytes acquire characteristics of NPCs after other types of injury. Whether NPCs arise in the human cortex in response to epilepsy or are present also in an intact cortical parenchyma is unknown. In our study, we found multipotent NPCs in cerebral cortex tissue from some but not all patients with focal cortical dysplasia and those with hippocampal sclerosis. It is conceivable that the presence of NPCs in the human cortex of epilepsy patients depends on parameters such as the underlying etiology, size of the epileptic focus, epilepsy duration, or plasticity responses triggered by epilepsy itself, by responses of astrocytes to epileptic seizures, or by epilepsy treatments prior to surgical intervention. Gonzalez-Martinez et al. (2007) described cortical neurogenesis in organotypic slices from patients with focal cortical dysplasia, possibly due to abnormal migration of cells from SVZ. It is, however, noteworthy that other investigators did not find newly formed neurons in human cortex, not even after stroke (Spalding et al. 2005; Bhardwaj et al. 2006; Huttner et al. 2014) . Human cortical NPCs therefore seem to be unable to differentiate into mature neurons in vivo. The functional significance of these cells in the human cortex remains to be determined. Nunes et al. (2003) suggested that in vitro A2B5 pos oligodendrocyte precursors from human subcortical white matter differentiate into all 3 cell lineages, that is, neurons, astrocytes, and oligodendrocytes. In our experiments, we used cerebral cortical tissue specimens that contained mostly gray matter. When we separated gray and white matter tissue prior to tissue dissociation, neurospheres formed from GLAST neg cells derived from both tissue preparations. In other experiments (data not shown), we separated white and gray matter of cerebral cortex specimen remote from the tumor of an astrocytoma grade IV tumor, and observed primary and secondary neurosphere formation from both the white matter-and gray matter-derived cells. Together, this suggests that cells with neurosphereforming capacity may also be derived from the gray matter of the human cerebral cortex. We observed that prior to differentiation, half of the proliferating neurosphere cells from specimen No. 14 expressed the proteoglycan NG2. NG2 is expressed by NG2-glia and by A2B5-positive oligodendrocyte precursors, 2 partially overlapping cell populations (Baracskay et al. 2007; Richardson et al. 2011 ). A2B5 antigen is expressed by the multipotent cells residing in human cortical white matter (Nunes et al. 2003) . It is possible that some of the GLAST neg cells with neurosphere-forming capacity described in this study were A2B5 pos oligodendrocyte precursor cells. However, Nunes et al. (2003) demonstrated that the A2B5 pos oligodendrocyte precursors predominantly differentiate into O4 pos oligodendrocytes in vitro, while in our study only 7% of the differentiated neurosphere cells expressed the O4 marker. Therefore, it is likely that neurospheres formed from other GLAST neg cell populations than oligodendrocyte precursors.
We observed a high percentage of differentiating cells co-expressing the astrocyte marker GFAP and neuronal markers βIII-tubulin or MAP2. These findings are in line with those of Laywell et al. (2005) who during neurosphere differentiation reported high occurrence of "asterons", hybrid cells expressing both astrocyte and neuronal markers, and linked this phenotype to cellular stress. We also observed that the cell fate of the differentiating neurosphere cells varied between the tissue specimens from individual patients. This variation might reflect differences in patients' gender, age, type and severity of epilepsy, comorbidities and treatment. Notably, we did not notice any association between the neurosphere-forming capacity or neurosphere cell differentiation pattern on one hand, and any of the clinical or histopathological parameters on the other hand (not shown).
To our knowledge, this is the first study that has assessed the NPC potential of GLAST pos astrocytes from human epileptic tissue outside the 2 neurogenic niches. We show that NPCs are present in the human epileptic cortex and demonstrate that these cells are GLAST neg . We found that GLAST pos astrocytes did not acquire NPC properties when cultured in vitro and are therefore not the source of NPCs in a chronic injury situation. The origin of these NPCs in the human epileptic cortex warrants further investigation.
